Prednisolone inhibits hyperosmolarity-induced expression of MCP-1 via NF-κB in peritoneal mesothelial cells

Kidney International

Volumn 69, Issue 4, 2006, Pages 736-746

  Matsuo, H ^a   Tamura, M ^b   Kabashima, N ^b   Serino, R ^a   Tokunaga, M ^b   Shibata, T ^a   Matsumoto, M ^a   Aijima, M ^a   Oikawa, S ^a   Anai, H ^a   Nakashima, Y ^a,b  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b School of Medicine   (Japan)

Author keywords

Biocompatibility of peritoneal dialysate; Continuous ambulatory peritoneal dialysis; Glucocorticoid; I B

Indexed keywords

DNA; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR ANTAGONIST; GLUCOSE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MANNITOL; MESSENGER RNA; MIFEPRISTONE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE 9; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; PREDNISOLONE; PROTEIN KINASE C; PROTEIN P22; PROTEIN P44; STRESS ACTIVATED PROTEIN KINASE 1;

ANIMAL CELL; ARTICLE; CELL ACTIVITY; CELL CULTURE; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA BINDING; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; FIBROSIS; GEL MOBILITY SHIFT ASSAY; HYPEROSMOLARITY; MESOTHELIUM CELL; MONOCYTE; NONHUMAN; PERITONEAL DISEASE; PERITONEUM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; CHEMOKINE CCL2; ENZYME ACTIVATION; EPITHELIUM; FIBROSIS; GENE EXPRESSION REGULATION; GLUCOSE; I-KAPPA B PROTEINS; MIFEPRISTONE; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; OSMOLAR CONCENTRATION; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PERITONEUM; PHOSPHORYLATION; PREDNISOLONE; PROTEIN KINASE C; RATS; RNA, MESSENGER;

EID: 32544444480     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5000131     Document Type: Article

References (50)

1. Pollock CA, Ibels LS, Eckstein RP et al. Peritoneal morphology on maintenance dialysis. Am J Nephrol 1989; 9: 198-204.
2. Topley N. Membrane longevity in peritoneal dialysis: impact of infection and bio-incompatible solutions. Adv Ren Replace Ther 1998; 5: 179-184.
3. Kawaguchi Y, Kawanishi H, Mujais S et al. Encapsulating peritoneal sclerosis: definition, etiology, diagnosis, and treatment. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis. Periton Dial Int 2000; 20: S43-S55.
4. Jorres A, Williams JD, Topley N. Peritoneal dialysis solution biocompatibility: inhibitory mechanisms and recent studies with bicarbonate-buffered solutions. Periton Dial Int 1997; 17: S42-S46.
5. Wang T, Chen YG, Ye RG et al. Effect of glucose on TGF-beta 1 expression in peritoneal mesothelial cells. Adv Periton Dial 1995; 11: 7-10.
6. Ogata S, Yorioka N, Kohno N. Glucose and prednisolone alter basic fibroblast growth factor expression in peritoneal mesothelial cells and fibroblasts. J Am Soc Nephrol 2001; 12: 2787-2796.
7. Ha H, Yu MR, Lee HB. High glucose-induced PKC activation mediates TGF-beta 1 and fibronectin synthesis by peritoneal mesothelial cells. Kidney Int 2001; 59: 463-470.
8. Ito T, Yorioka N, Yamamoto M et al. Effect of glucose on intercellular junctions of cultured human peritoneal mesothelial cells. J Am Soc Nephrol 2000; 11: 1969-1979.
9. Tamura M, Osajima A, Nakayamada S et al. High glucose levels inhibit focal adhesion kinase-mediated wound healing of rat peritoneal mesothelial cells. Kidney Int 2003; 63: 722-731.
10. Topley N, Liberek T, Davenport A et al. Activation of inflammation and leukocyte recruitment into the peritoneal cavity. Kidney Int Suppl 1996; 56: S17-S21.
11. Polubinska A, Pawlaczyk K, Kuzlan-Pawlaczyk M et al. Dialysis solution containing hyaluronan: effect on peritoneal permeability and inflammation in rats. Kidney Int 2000; 57: 1182-1189.
12. Li FK, Davenport A, Robson RL et al. Leukocyte migration across human peritoneal mesothelial cells is dependent on directed chemokine secretion and ICAM-1 expression. Kidney Int 1998; 54: 2170-2183.
13. Suda T, Osajima A, Tamura M et al. Pressure-induced expression of monocyte chemoattractant protein-1 through activation of MAP kinase. Kidney Int 2001; 60: 1705-1715.
14. Rovin BH, Wilmer WA, Danne M et al. The mitogen-activated protein kinase p38 is necessary for interleukin 1beta-induced monocyte chemoattractant protein 1 expression by human mesangial cells. Cytokine 1999; 11: 118-126.
15. Rovin BH, Tan LC. Role of protein kinase pathways in IL-1-induced chemoattractant expression by human mesangial cells. Kidney Int 1994; 46: 1059-1068.
16. Watanabe Y, Tamura M, Osajima A et al. Integrins induce expression of monocyte chemoattractant protein-1 via focal adhesion kinase in mesangial cells. Kidney Int 2003; 64: 431-440.
17. Rovin BH, Dickerson JA, Tan LC, Hebert CA. Activation of nuclear factor-kappa B correlates with MCP-1 expression by human mesangial cells. Kidney Int 1995; 48: 1263-1271.
18. Ha H, Yu MR, Choi YJ et al. Role of high glucose-induced nuclear factor-kappaB activation in monocyte chemoattractant protein-1 expression by mesangial cells. J Am Soc Nephrol 2002; 13: 894-902.
19. Haslinger B, Mandl-Weber S, Sellmayer A et al. Effect of high glucose concentration on the synthesis of monocyte chemoattractant protein-1 in human peritoneal mesothelial cells: involvement of protein kinase C. Nephron 2001; 87: 346-351.
20. Lee SK, Kim BS, Yang WS et al. High glucose induces MCP-1 expression partly via tyrosine kinase-AP-1 pathway in peritoneal mesothelial cells. Kidney Int 2001; 60: 55-64.
21. Barnes PJ, Adcock I. Anti-inflammatory actions of steroids: molecular mechanisms. Trends Pharmacol Sci 1993; 14: 436-441.
22. Imai H, Nakamoto H, Fucshima R et al. Glucocorticoid protects against the development of encapsulating peritoneal sclerosis on peritoneal dialysis. Adv Periton Dial 2002; 18: 124-130.
23. Cadepond F, Ulmann A, Baulieu EE. RU486 (mifepristone): mechanisms of action and clinical uses. Annu Rev Med 1997; 48: 129-156.
24. Scheinman RI, Cogswell PC, Lofquist AK, Baldwin Jr AS. Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science 1995; 270: 283-286.
25. Auphan N, DiDonato JA, Rosette C et al. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 1995; 270: 286-290.
26. Ray A, Prefontaine KE. Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor. Proc Natl Acad Sci USA 1994; 91: 752-756.
27. Ogata S, Yorioka N. Effect of prednisolone on increased expression of laminin by human peritoneal mesothelial cells cultured with high glucose. Adv Periton Dial 2001; 17: 2-4.
28. Kawanao H, Kim S, Ohta K et al. Differential contribution of three mitogen-activated protein kinases to PDGF-BB-induced mesangial cell proliferation and gene expression. J Am Soc Nephrol 2003; 14: 584-592.
29. Kato S, Yuzawa Y, Tsuboi N et al. Endotoxin-induced chemokine expression in murine peritoneal mesothelial cells: the role of toll-like receptor 4. J Am Soc Nephrol 2004; 15: 1289-1299.
30. Baldwin Jr AS. The NF-kappa B and I kappa B proteins: new discoveries and insights. Anna Rev Immunol 1996; 14: 649-683.
31. Sheppard KA, Phelps KM, Williams AJ et al. Nuclear integration of glucocorticoid receptor and nuclear factor-kappaB signaling by CREB-binding protein and steroid receptor coactivator-1. J Biol Chem 1998; 273: 29291-29294.
32. De Bosscher K, Vanden Berghe W, Vermeulen L et al. Glucocorticoids repress NF-kappaB-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cell. Proc Natl Acad Sci USA 2000; 97: 3919-3924.
33. Spahn JD, Szefler SJ, Surs W et al. A novel action of IL-13: induction of diminished monocyte glucocorticoid receptor-binding affinity. J Immunol 1996; 157: 2654-2659.
34. Yan K, Kudo A, Hirano H et al. Subcellular localization of glucocorticoid receptor protein in the human kidney glomerulus. Kidney Int 1999; 56: 65-73.
35. Salkowski CA, Vogel SN. Lipopolysaccharide increases glucocorticoid receptor expression in murine macrophages. A possible mechanism for glucocorticoid-mediated suppression of endotoxicity. J Immunol 1992; 149: 4041-4047.
36. Cronstein BN, Kimmel SC, Levin RI et al. A mechanism for the antiinflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1. Proc Natl Acad Sci USA 1992; 89: 9991-9995.
37. Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997; 336: 1066-1071.
38. Muller M, Morotti A, Ponzetto C. Activation of NF-kappaB is essential for hepatocyte growth factor-mediated proliferation and tubulogenesis. Mol Cell Biol 2002; 22: 1060-1072.
39. Schmitz ML, Bacher S, Dienz O. NF-kappaB activation pathways induced by T cell costimulation. FASEB J 2003; 17: 2187-2193.
40. Martin T, Cardarelli PM, Parry GC et al. Cytokine induction of monocyte chemoattractant protein-1 gene expression in human endothelial cells depends on the cooperative action of NF-kappa B and AP-1. Eur J Immunol 1997; 27: 1091-1097.
41. Gottlicher M, Heck S, Herrlich P. Transcriptional cross-talk, the second mode of steroid hormone receptor action. J Mol Med 1998; 76: 480-489.
42. Rovin BH, Rumancik M, Tan L, Dickerson J. Glomerular expression of monocyte chemoattractant protein-1 in experimental and human glomerulonephritis. Lab Invest 1994; 71: 536-542.
43. Banba N, Nakamura T, Matsumura M et al. Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy. Kidney Int 2000; 58: 684-690.
44. Visser CE, Tekstra J, Brouwer-Steenbergen JJ et al. Chemokines produced by mesothelial cells: huGRO-alpha IP-10, MCP-1 and RANTES. Clin Exp Immunol 1998; 112: 270-275.
45. Wong TY, Phillips AO, Witowski J, Topley N. Glucose-mediated induction of TGF-beta 1 and MCP-1 in mesothelial cells in vitro is osmolality and polyol pathway dependent. Kidney Int 2003; 63: 1404-1416.
46. Tamura M, Gu J, Danen EH et al. PTEN interactions with focal adhesion kinase and suppression of the extracellular matrix-dependent phosphatidylinositol 3-kinase/Akt cell survival pathway. J Biol Chem 1999; 274: 20693-20703.
47. Tamura M, Gu J, Matsumoto K et al. Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science 1998; 280: 1614-1617.
48. Gu J, Tamura M, Pankov R et al. Shc and FAK differentially regulate cell motility and directionality modulated by PTEN. J Cell Biol 1999; 146: 389-403.
49. Tamura M, Tanaka H, Yashiro A et al. Expression of profiling, an actin-binding protein, in rat experimental glomerulonephritis and its upregulation by basic fibroblast growth factor in cultured rat mesangial cells. J Am Soc Nephrol 2000; 11: 423-433.
50. Tamura M, Yanagihara N, Tanaka H et al. Activation of DNA synthesis and AP-1 by profilin, an actin-binding protein, via binding to a cell surface receptor in cultured rat mesangial cells. J Am Soc Nephrol 2000; 11: 1620-1630.